Cost-effectiveness Analysis of Trilaciclib for Preventing Myelosuppression in Small Cell Lung Cancer Patients Treated with Etoposide, Carboplatin, and Atezolizumab.
American journal of cancer research（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined